3026 - 3050 of 9141 Results
Title
Year
- Optimized machine learning methods for prediction of cognitive outcome in Parkinson's disease2019RESTRICTEDTitle: Optimized machine learning methods for prediction of cognitive outcome in Parkinson's diseaseJournal Name: Computers in Biology and MedicinePublisher: Elsevier BVVol: 111Issue #:Start Page: 103347End Page: 103347Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.compbiomed.2019.103347Citation Count: 60
- Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic features2023OPENTitle: Prediction of Parkinson’s disease pathogenic variants using hybrid Machine learning systems and radiomic featuresJournal Name: Physica MedicaPublisher: Elsevier BVVol: 113Issue #:Start Page: 102647End Page: 102647Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.ejmp.2023.102647Citation Count: 23
-
OPENTitle: Influence of analytic techniques on comparing DTI-derived measurements in early stage Parkinson's diseaseJournal Name: HeliyonPublisher: Elsevier BVVol: 5Issue #: 4Start Page: e01481End Page: e01481Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.heliyon.2019.e01481Best OA location URL: http://www.cell.com/article/S2405844018372189/pdfCitation Count: 22
- Chronotype, sleep, and sleepiness in Parkinson's disease2022RESTRICTEDTitle: Chronotype, sleep, and sleepiness in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 106Issue #:Start Page: 105189End Page: 105189Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.011Citation Count: 11
- Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's Disease2024OPENTitle: Neuroanatomical Signature of the Transition from Normal Cognition to MCI in Parkinson's DiseaseJournal Name: Aging and diseasePublisher: Aging and DiseaseVol: 16Issue #: 1Start Page: 619End Page: 619Publication Date:Open Access(OA) Status: OPENLicense: other-oaDOI - Digital Object Identifier: 10.14336/ad.2024.0323Best OA location URL: https://www.aginganddisease.org/EN/PDF/10.14336/AD.2024.0323Citation Count: 8
- An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural Networks2024RESTRICTEDTitle: An analysis of data leakage and generalizability in MRI based classification of Parkinson's Disease using explainable 2D Convolutional Neural NetworksJournal Name: Digital Signal ProcessingPublisher: Elsevier BVVol: 147Issue #:Start Page: 104407End Page: 104407Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.dsp.2024.104407Citation Count: 25
- Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI dataset2022RESTRICTEDTitle: Renin-angiotensin system blockers affect cognitive decline in Parkinson's disease: The PPMI datasetJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 90End Page: 95Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.019Citation Count: 24
-
OPENTitle: Brain network characteristics and cognitive performance in motor subtypes of Parkinson's disease: A resting state fMRI studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 105Issue #:Start Page: 32End Page: 38Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1016/j.parkreldis.2022.10.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2022.10.027Citation Count: 9
- Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's disease2021RESTRICTEDTitle: Low soluble amyloid-β 42 is associated with smaller brain volume in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 92Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.10.010Citation Count: 11
-
OPENTitle: Analysis of a precision medicine approach to treating Parkinson's disease: Analysis of the DATATOP studyJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 94Issue #:Start Page: 15End Page: 21Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.11.027Best OA location URL: https://doi.org/10.1016/j.parkreldis.2021.11.027Citation Count: 8
- Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's disease2021RESTRICTEDTitle: Subcortical microstructural diffusion changes correlate with gait impairment in Parkinson's diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 87Issue #:Start Page: 111End Page: 118Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2021.05.005Citation Count: 15
-
OPENTitle: M1 Muscarinic Receptors Modulate Fear-Related Inputs to the Prefrontal Cortex: Implications for Novel Treatments of Posttraumatic Stress DisorderJournal Name: Biological PsychiatryPublisher: Elsevier BVVol: 85Issue #: 12Start Page: 989End Page: 1000Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1016/j.biopsych.2019.02.020Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/6555658Citation Count: 35
- Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent manner2017RESTRICTEDTitle: Chelerythrine promotes Ca2+-dependent calpain activation in neuronal cells in a PKC-independent mannerJournal Name: Biochimica et Biophysica Acta (BBA) - General SubjectsPublisher: Elsevier BVVol: 1861Issue #: 4Start Page: 922End Page: 935Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.bbagen.2017.01.021Citation Count: 18
-
OPENTitle: Full sequencing and haplotype analysis of MAPT in Parkinson's disease and rapid eye movement sleep behavior disorderJournal Name: Movement DisordersPublisher: WileyVol: 33Issue #: 6Start Page: 1016End Page: 1020Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1002/mds.27385Best OA location URL: http://hdl.handle.net/11380/1205920Citation Count: 41
- The role of disease duration and severity on novel clinical subtypes of Parkinson disease2020RESTRICTEDTitle: The role of disease duration and severity on novel clinical subtypes of Parkinson diseaseJournal Name: Parkinsonism & Related DisordersPublisher: Elsevier BVVol: 73Issue #:Start Page: 31End Page: 34Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.parkreldis.2020.03.013Citation Count: 17
-
OPENTitle: Cortical volume abnormalities in posttraumatic stress disorder: an ENIGMA-psychiatric genomics consortium PTSD workgroup mega-analysisJournal Name: Molecular PsychiatryPublisher: Springer Science and Business Media LLCVol: 26Issue #: 8Start Page: 4331End Page: 4343Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1038/s41380-020-00967-1Best OA location URL: https://www.nature.com/articles/s41380-020-00967-1.pdfCitation Count: 96
- Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competition2019OPENTitle: Factors in the disease severity of ATP1A3 mutations: Impairment, misfolding, and allele competitionJournal Name: Neurobiology of DiseasePublisher: Elsevier BVVol: 132Issue #:Start Page: 104577End Page: 104577Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nbd.2019.104577Best OA location URL: https://doi.org/10.1016/j.nbd.2019.104577Citation Count: 45
-
OPENTitle: Free-water imaging of the hippocampus is a sensitive marker of Alzheimer's diseaseJournal Name: NeuroImage: ClinicalPublisher: Elsevier BVVol: 24Issue #:Start Page: 101985End Page: 101985Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-ndDOI - Digital Object Identifier: 10.1016/j.nicl.2019.101985Best OA location URL: https://doi.org/10.1016/j.nicl.2019.101985Citation Count: 69
- Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damage2015OPENTitle: Microglial Hv1 proton channel promotes cuprizone‐induced demyelination through oxidative damageJournal Name: Journal of NeurochemistryPublisher: WileyVol: 135Issue #: 2Start Page: 347End Page: 356Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1111/jnc.13242Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/jnc.13242Citation Count: 72
-
RESTRICTEDTitle: Symmetry of synuclein density in autopsied Parkinson’s disease submandibular glandsJournal Name: Neuroscience LettersPublisher: Elsevier BVVol: 825Issue #:Start Page: 137702End Page: 137702Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1016/j.neulet.2024.137702Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/10942751Citation Count: 0
- Lewy body pathology in Alzheimer's disease: A clinicopathological prospective study2018RESTRICTEDTitle: Lewy body pathology in Alzheimer's disease: A clinicopathological prospective studyJournal Name: Acta Neurologica ScandinavicaPublisher: WileyVol: 139Issue #: 1Start Page: 76End Page: 81Publication Date:Open Access(OA) Status: RESTRICTEDLicense:DOI - Digital Object Identifier: 10.1111/ane.13028Citation Count: 54
-
OPENTitle: Assessing Gq-GPCR–induced human astrocyte reactivity using bioengineered neural organoidsJournal Name: Journal of Cell BiologyPublisher: Rockefeller University PressVol: 221Issue #: 4Start Page:End Page:Publication Date:Open Access(OA) Status: OPENLicense: cc-by-nc-saDOI - Digital Object Identifier: 10.1083/jcb.202107135Best OA location URL: https://rupress.org/jcb/article-pdf/221/4/e202107135/1428539/jcb_202107135.pdfCitation Count: 27
-
OPENTitle: Discovery of a Pyrrolopyrimidine (JH-II-127), a Highly Potent, Selective, and Brain Penetrant LRRK2 InhibitorJournal Name: ACS Medicinal Chemistry LettersPublisher: American Chemical Society (ACS)Vol: 6Issue #: 5Start Page: 584End Page: 589Publication Date:Open Access(OA) Status: OPENLicense:DOI - Digital Object Identifier: 10.1021/acsmedchemlett.5b00064Best OA location URL: https://www.ncbi.nlm.nih.gov/pmc/articles/4434483Citation Count: 57
-
OPENTitle: Methods to Study the Molecular Mechanism and Drive the Design of Protein DegradersJournal Name: Chemical ReviewsPublisher: American Chemical Society (ACS)Vol: 126Issue #: 10Start Page: 5755End Page: 5791Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1021/acs.chemrev.5c00800Best OA location URL: https://doi.org/10.1021/acs.chemrev.5c00800Citation Count: 0
-
OPENTitle: Evaluation of the detection of GBA missense mutations and other variants using the Oxford Nanopore MinIONJournal Name: Molecular Genetics & Genomic MedicinePublisher: WileyVol: 7Issue #: 3Start Page: e564End Page: e564Publication Date:Open Access(OA) Status: OPENLicense: cc-byDOI - Digital Object Identifier: 10.1002/mgg3.564Best OA location URL: https://onlinelibrary.wiley.com/doi/pdfdirect/10.1002/mgg3.564Citation Count: 94